Insider Shareholders with Direct Ownership of New Amsterdam Pharma CO N.V. (NAMS)
This section provides a comprehensive overview of the insiders with direct ownership of New Amsterdam Pharma CO N.V. (NAMS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
NewAmsterdam Pharma Co N.V. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Michael H. Davidson
Chief Executive Officer |
133,529 | 0 | 123,529 | 3 |
Jan 07, 2025
Added 50.0%
|
|
Douglas F Kling
Chief Operating Officer |
244,000 | 200,000 | 44,000 | 9 |
Jan 30, 2025
Reduced 16.85%
|
|
William A Jones Jr
Chief Commercial Officer |
43,000 | 0 | 43,000 | 1 |
Jan 07, 2025
Added 50.0%
|
|
Mayur Ian Somaiya
Chief Financial Officer |
99,883 | 61,883 | 38,000 | 5 |
Jan 28, 2025
Reduced 8.22%
|
|
Johannes Jacob Pieter Kastelein
Chief Scientific Officer |
34,000 | 0 | 34,000 | 1 |
Jan 07, 2025
Added 50.0%
|
|
Juliette Berangere Audet
Chief Business Officer |
15,104 | 0 | 15,104 | 2 |
Jan 07, 2025
Added 48.1%
|
|
Louise Frederika Kooij
Chief Accounting Officer |
60,000 | 45,000 | 15,000 | 3 |
Jan 07, 2025
Added 50.0%
|
| 6,960 | 0 | 6,960 | 1 |
Jan 07, 2025
Added 50.0%
|
|
| 6,960 | 0 | 6,960 | 1 |
Jan 07, 2025
Added 50.0%
|
|
| 6,960 | 0 | 6,960 | 1 |
Jan 07, 2025
Added 50.0%
|
|
| 6,960 | 0 | 6,960 | 1 |
Jan 07, 2025
Added 50.0%
|
|
| 6,960 | 0 | 6,960 | 1 |
Jan 07, 2025
Added 50.0%
|